Loading clinical trials...
Loading clinical trials...
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Pharmacokinetics and Efficacy of Intravenous Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labour
Conditions
Interventions
Serelaxin
Placebo
Locations
3
Russia
Novosibirsk State Medical Academy
Novosibirsk, Russia
Evidence CPR
Saint Petersburg, Russia
D.O. Ott Research Institute of Obstetrics and Gynecology
Saint Petersburg, Russia
Start Date
November 1, 2005
Primary Completion Date
October 1, 2006
Completion Date
October 1, 2006
Last Updated
May 7, 2014
NCT06591247
NCT05109247
NCT00308711
NCT00992524
Lead Sponsor
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions